Number of the records: 1  

Pseurotin D Inhibits the Activation of Human Lymphocytes

  1. 1.
    SYSNO ASEP0542080
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePseurotin D Inhibits the Activation of Human Lymphocytes
    Author(s) Rubanová, Daniela (BFU-R)
    Daďová, Petra (BFU-R) ORCID
    Vašíček, Ondřej (BFU-R) ORCID, RID
    Kubala, Lukáš (BFU-R) RID, ORCID
    Number of authors4
    Article number1938
    Source TitleInternational Journal of Molecular Sciences. - : MDPI
    Roč. 22, č. 4 (2021)
    Number of pages14 s.
    Publication formOnline - E
    Languageeng - English
    CountryCH - Switzerland
    Keywordspseurotin ; lymphocyte ; stat3 ; stat5 ; proliferation
    Subject RIVCE - Biochemistry
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsGA17-18858S GA ČR - Czech Science Foundation (CSF)
    Method of publishingOpen access
    Institutional supportBFU-R - RVO:68081707
    UT WOS000623785200001
    EID SCOPUS85101032195
    DOI10.3390/ijms22041938
    AnnotationBackground: Pseurotins, a family of secondary metabolites of different fungi characterized by an unusual spirocyclic furanone-lactam core, are suggested to have different biological activities including the modulation of immune response. Purpose: Complex characterization of the effects of pseurotin D on human lymphocyte activation in order to understand the potential of pseurotin to modulate immune response in humans. Methods: CD4+ and CD8+ T cells and CD19+ B cells isolated from human blood were activated by various activators simultaneously with pseurotin D treatment. The effects of pseurotin were tested on the basis of changes in cell viability, apoptosis, activation of signal transducers and activators of transcription (STAT) signaling pathways, production of tumor necrosis factor (TNF)-alpha by T cells, expression of activation markers CD69 and CD25 on T cells and Human Leukocyte Antigen-DR isotype (HLA-DR) on B cells, and the differentiation markers CD20, CD27, CD38, and immunoglobulin (Ig) D on B cells. Results: Pseurotin D significantly inhibited the activation of both CD4+ and CD8+ human T cells complemented by the inhibition of TNF-alpha production without significant acute toxic effects. The Pseurotin D-mediated inhibition of T-cell activation was accompanied by the induction of the apoptosis of T cells. This corresponded with the inhibited phosphorylation of STAT3 and STAT5. In human B cells, pseurotin D did not significantly inhibit their activation, however, it affected their differentiation. Conclusions: Our results advance the current mechanistic understanding of the pseurotin-induced inhibition of lymphocytes and suggest pseurotins as new attractive chemotypes for future research in the context of immune-modulatory drugs.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2022
    Electronic addresshttps://www.mdpi.com/1422-0067/22/4/1938
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.